EcoR1 Capital LLC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 2:15 pm Sale |
2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
EcoR1 Capital LLC | 253,897 1.700% |
-111,111 (-30.44%) |
Filing |
| 2021-02-12 4:15 pm Purchase |
2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
EcoR1 Capital LLC | 365,008 5.400% |
132,744 (+57.15%) |
Filing |